On 4/27 Dr. Pourhassan said they submitted the BLA
Post# of 148179
He probably did not know at that time, the FDA would get back they needed information or possibly even just clarification for clinical datasets from March...
Quote:
The clinical datasets are updated to address FDA comments for mock datasets from March 12 and March 20, 2020.
Remember there were a couple of PRs out without anything about that (April 29th and April 30th) and not for a whole week later, until the May 4th PR did they update under the title of Leronlimab ...
Friday morning quarterbacking by people now is just hindsight...
https://investorshangout.com/post/view?id=5760890